BWX Technologies, Inc. (BWXT)
After hours:
| Previous Close | 98.73 |
| Open | 100.00 |
| Bid | 98.73 x 1100 |
| Ask | 99.58 x 800 |
| Day's Range | 99.02 - 100.40 |
| 52 Week Range | 68.14 - 107.18 |
| Volume | |
| Avg. Volume | 554,881 |
| Market Cap | 9.062B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 35.92 |
| EPS (TTM) | 2.76 |
| Earnings Date | Aug 05, 2024 |
| Forward Dividend & Yield | 0.96 (0.97%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | 108.20 |
ZacksCelestica (CLS) Beats Q2 Earnings and Revenue Estimates
Celestica (CLS) delivered earnings and revenue surprises of 10.98% and 6.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireBWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production
OTTAWA, Ontario & BELOIT, Wis., July 22, 2024--BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.
StockStoryQ1 Earnings Highlights: BWX (NYSE:BWXT) Vs The Rest Of The Defense Contractors Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how BWX (NYSE:BWXT) and the rest of the defense contractors stocks fared in Q1.
